3986 Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Cerilliant 

Corporation 

ACTION: Notice of registration. 

SUMMARY: Cerilliant Corporation applied 

to be registered as a manufacturer of 

certain basic classes of controlled 

substances. The DEA grants Cerilliant 

Corporation registration as a 

manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated August 19, 2014, and published in 

the Federal Register on August 26, 

2014, 79 FR 50948, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78665–2402, 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Cerilliant Corporation to manufacture 

the basic classes of controlled 

substances is consistent with the public 

interest and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971. The DEA investigated the 

company’s maintenance of effective 

controls against diversion by inspecting 

and testing the company’s physical 

security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled 

Substance Schedule 

3-Fluoro-N-methylcathinone (3– 

FMC) (1233).

I 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

4-Fluoro-N-methylcathinone (4– 

FMC) (1238).

I 

Pentedrone (amethylaminovalerophenone) 

(1246).

I 

Mephedrone (4-(Methyl-Nmethylcathinone) (1248).I 

4-Methyl-N-ethylcathinone (4– 

MEC) (1249).

I 

Naphyrone (1258) ........................ I 

Controlled 

Substance Schedule 

N-Ethylamphetamine (1475) ........ I 

N,N-Dimethylamphetamine (1480) I 

Fenethylline (1503) ....................... I 

Aminorex (1585) ........................... I 

4-Methylaminorex (cis isomer) 

(1590).

I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

JWH–250 (1-Pentyl-3-(2- 

methoxyphenylacetyl) indole) 

(6250).

SR–18 and RCS–8 (1- 

Cyclohexylethyl-3-(2- 

methoxyphenylacetyl) indole) 

(7008).

5-Flouro-UR–144 and XLR11 [1- 

(5-Fluoro-pentyl) 1H-indol-3- 

yl](2,2,3,3- 

tetramethylcyclopropyl) 

methanone (7011).

I 

AB–FUBINACA (N-(1-amino-3- 

methyl-1-oxobutan-2-yl)-1-(4- 

fluorobenzyl)-1H-indazole-3- 

carboxamide) (7012).

I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019).I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- 

pentyl-1H-indazole-3- 

carboxamide) (7035).

I 

APINACA and AKB48 N-(1- 

Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048).

I 

JWH–081 (1-Pentyl-3-(1-(4- 

methoxynaphthoyl) indole) 

(7081).

I 

SR–19 and RCS–4 (1-Pentyl-3[(4- 

methoxy)-benzoyl] indole 

(7104).

I 

JWH–018 (also known as AM678) 

(1-Pentyl-3-(1-naphthoyl)indole) 

(7118).

I 

JWH–122 (1-Pentyl-3-(4-methyl-1- 

naphthoyl) indole) (7122).

I 

UR–144 (1-Pentyl-1H-indol-3- 

yl)(2,2,3,3- 

tetramethylcyclopropyl)methanone (7144).

I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173).I 

JWH–200 (1-[2-(4- 

Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200).

I 

AM–2201 (1-(5-Fluoropentyl)-3-(1- 

naphthoyl) indole) (7201).

I 

JWH–203 (1-Pentyl-3-(2- 

chlorophenylacetyl) indole) 

(7203).

I 

PB–22 (Quinolin-8-yl 1-pentyl-1Hindole-3-carboxylate) (7222).I 

5F–PB–22 (Quinolin-8-yl 1-(5- 

fluoropentyl)-1H-indole-3- 

carboxylate) (7225).

I 

Alpha-ethyltryptamine (7249) ....... I 

CP–47,497 (5-(1,1- 

Dimethylheptyl)-2-[(1R,3S)-3- 

hydroxycyclohexyl-phenol) 

(7297).

I 

CP–47,497 C8 Homologue (5- 

(1,1-Dimethyloctyl)-2-[(1R,3S) 

3-hydroxycyclohexyl-phenol) 

(7298).

I 

Controlled 

Substance Schedule 

Lysergic acid diethylamide (7315) I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine (2C– 

T–7) (7348).

I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Parahexyl (7374) .......................... I 

Mescaline (7381) .......................... I 

2-(4-Ethylthio-2,5- 

dimethoxyphenyl) ethanamine 

(2C–T–2) (7385).

I 

3,4,5–Trimethoxyamphetamine 

(7390).

I 

4-Bromo–2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo–2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

JWH–398 (1-Pentyl-3-(4-chloro-1- 

naphthoyl) indole (7398).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

5-Methoxy-3,4- 

methylenedioxyamphetamine 

(7401).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (7405).

I 

4-Methoxyamphetamine (7411) ... I 

5-Methoxy-N–Ndimethyltryptamine (7431).I 

Alpha-methyltryptamine (7432) .... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

Controlled Substance Schedule.

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

N-Ethyl-1-phenylcyclohexylamine 

(7455).

I 

1-(1-Phenylcyclohexyl)pyrrolidine 

(7458).

I 

1-[1-(2- 

Thienyl)cyclohexyl]piperidine 

(7470).

I 

N-Benzylpiperazine (7493) ........... I 

4-Methylalphapyrrolidinopropiophenone 

(4-mePPP) (7498).

I 

2-(2,5-Dimethoxy-4-methylphenyl) 

ethanamine (2C–D) (7508).

I 

2-(2,5-Dimethoxy-4-methylphenyl) 

ethanamine (2C–E) (7509).

I 

2-(2,5-Dimethoxyphenyl) 

ethanamine (2C–H) (7517).

I 

2-(4-lodo-2,5-dimethoxyphenyl) 

ethanamine (2C–I) (7518).

I 

2-(4-Chloro-2,5-dimethoxyphenyl) 

ethanamine (2C–C) (7519).

I 


emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 3987 

Controlled 

Substance Schedule 

2-(2,5-Dimethoxy-4-nitro-phenyl) 

ethanamine (2C–N) (7521).

I 

2-(2,5-Dimethoxy-4-(n)- 

propylphenyl) ethanamine (2C– 

P) (7524).

I 

2-(4-Isopropylthio)-2,5- 

dimethoxyphenyl) ethanamine 

(2C–T–4) (7532).

I 

MDPV (3,4- 

Methylenedioxypyrovalerone) 

(7535).

I 

2-(4-bromo-2,5-dimethoxyphenyl)- 

N-(2-methoxybenzyl) 

ethanamine (25B–NBOMe) 

(7536).

I 

2-(4-chloro-2,5-dimethoxyphenyl)- 

N-(2-methoxybenzyl) 

ethanamine (25C–NBOMe) 

(7537).

I 

2-(4-iodo-2,5-dimethoxyphenyl)-N- 

(2-methoxybenzyl) ethanamine 

(25I–NBOMe) (7538).

I 

Methylone (3,4-Methylenedioxy-Nmethylcathinone) (7540).I 

Butylone (7541) ............................ I 

Pentylone (7542) .......................... I 

alpha-pyrrolidinopentiophenone 

(a-PVP) (7545).

I 

alpha-pyrrolidinobutiophenone (a 

-PBP) (7546).

I 

AM–694 (1-(5-Fluoropentyl)-3-(2- 

iodobenzoyl) indole) (7694).

I 

Acetyldihydrocodeine (9051) ........ I 

Benzylmorphine (9052) ................ I 

Codeine-N-oxide (9053) ............... I 

Desomorphine (9055) ................... I 

Codeine methylbromide (9070) .... I 

Dihydromorphine (9145) ............... I 

Heroin (9200) ............................... I 

Hydromorphinol (9301) ................. I 

Methyldesorphine (9302) .............. I 

Methyldihydromorphine (9304) ..... I 

Morphine methylbromide (9305) .. I 

Morphine methylsulfonate (9306) I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Pholcodine (9314) ........................ I 

Acetylmethadol (9601) ................. I 

Allylprodine (9602) ....................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Betacetylmethadol (9607) ............ I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Dipipanone (9622) ........................ I 

Hydroxypethidine (9627) .............. I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) .................. I 

Trimeperidine (9646) .................... I 

Phenomorphan (9647) ................. I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

Tilidine (9750) ............................... I 

Para-Fluorofentanyl (9812) .......... I 

3-Methylfentanyl (9813) ................ I 

Alpha-methylfentanyl (9814) ........ I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Beta-hydroxyfentanyl (9830) ........ I 

Controlled 

Substance Schedule 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Alpha-methylthiofentanyl (9832) ... I 

3-Methylthiofentanyl (9833) .......... I 

Thiofentanyl (9835) ...................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Nabilone (7379) ............................ II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

1- 

Piperidinocyclohexanecarbonitrile (8603).

II 

Alphaprodine (9010) ..................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Metazocine (9240) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Racemethorphan (9732) .............. II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Carfentanil (9743) ......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01300 Filed 1–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Apertus 

Pharmaceuticals 

ACTION: Notice of registration. 

SUMMARY: Apertus Pharmaceuticals 

applied to be registered as a 

manufacturer of a certain basic class of 

controlled substance. The DEA grants 

Apertus Pharmaceuticals registration as 

a manufacturer of the controlled 

substance. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 4, 2014, 79 

FR 32321, Apertus Pharmaceuticals, 331 

Consort Drive, St. Louis, Missouri 

63011, applied to be registered as a 

manufacturer of a certain basic class of 

controlled substance. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Apertus Pharmaceuticals to 

manufacture the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of Remifentanil (9739), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to manufacture 

small quantities of the listed controlled 

substance to make reference standards 

for distribution to their customers. 

On March 27, 2014, Apertus 

Pharmaceuticals withdrew its request 

for the addition of Alfentanil (9737), 

Sufentanil (9740), and Fentanyl (9801) 

to this registration. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01306 Filed 1–23–15; 8:45 am] 

BILLING CODE P 


emcdonald on DSK67QTVN1PROD with NOTICES